65,437 trials
CD20 Positive · Hematopoietic and Lymphoid Cell Neoplasm · Lymphocytic Neoplasm
Primary: Number of Participants With Dose Limiting Toxicity (DLT) — 0; 0; 0 Participants
Breast Cancer
Primary: Phase I Portion: Maximum Tolerated Dose/MTD of Dasatinib When Administered in Combination With a Fixed Dose of Weekly Paclitaxel. — 120 mg of dasatinib
Cutaneous T Cell Lymphoma
Primary: The Number of Participants That Tolerated the Maximum Drug Dose — 8; 4 Participants
Neuroblastoma
Primary: Assess the Activity of High-dose 3F8/GM-CSF
Renal Artery Stenosis · Hypertension, Renovascular
Primary: Primary Patency — 66 Subject-lesions — p=<.0001
Tobacco Use Cessation · Tobacco Smoking
Primary: Number of Participants Referred — 1380; 331 Participants — p=<.0001
Obstructive Sleep Apnea
Primary: Apnea-Hypopnea Index — 6.09; 3.54; 3.24; 1.26 events/hour — p=0.3
Lymphoma, Non-Hodgkin
Primary: Kaplan Meier Estimate of Progression Free Survival Assessed by the Independent Review Committee (IRC) According to the 2007 International Working Group Response Criteria…
Anaplastic Astrocytoma · Brain Stem Glioma · Childhood Mixed Glioma
Primary: Maximum-tolerated Dose of Veliparib Defined as Highest Dose Level With Fewer Than 2 Dose Limiting Toxicities in 6 Patients as Assessed by the National Cancer Institute…
Chronic Kidney Disease
Primary: Kaplan-Meier Estimate of Secondary AVF Patency — NA; NA Days — p=0.932
Osteoarthritis
Primary: Pain Scores Measured by Western Ontario and McMaster Universities Index (WOMAC) Survey — 3.98; 5.54 units on a scale
Multiple Sclerosis, Relapsing-Remitting
Primary: Fatigue at 28 Weeks — 56.50; 29.00; 55.00; 40.00 score on a scale
Choroidal Neovascularization · Macular Edema · Glaucoma, Neovascular
Primary: Number of Participants With Adverse Events as a Measure of Safety and Tolerability — 2; 21; 1; 0 Participants
Kidney; Complications, Allograft
Primary: Baseline eGFR (Estimated Glomerular Filtration Rate) — 30.04; 30.04 mL/min/1.73 m2
Bacteremia · Bacterial Infection
Primary: Demonstrate Safety of the ExThera Medical Seraph® 100 Microbind® Affinity Blood Filter in a Hemodialysis Circuit Assessed by Rate of Adverse Events. — 0 Percent…